The ALS Association logo

The ALS Association

North America, District of Columbia, United States, Washington

Description

The ALS Association is the only national non-profit organization fighting Lou Gehrigs Disease on every front.

Investor Profile

The ALS Association has made 12 investments, with 3 in the past 12 months and 92% as lead.

Stage Focus

  • Grant (92%)
  • Seed (8%)

Country Focus

  • United States (50%)
  • France (17%)
  • Spain (8%)
  • United Kingdom (8%)
  • Israel (8%)
  • Switzerland (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Neuroscience
  • Genetics
  • Artificial Intelligence (Ai)
  • Cloud Computing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The ALS Association frequently co-invest with?

ALS Finding a Cure
North America, Florida, United States, Boynton Beach
Co-Investments: 2
Innosuisse
Europe, Bern, Switzerland, Berne
Co-Investments: 1

What are some of recent deals done by The ALS Association?

Modulo Bio

San Diego, California, United States

Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.

BiopharmaBiotechnologyMedicalProduct Research
GrantFeb 7, 2025
Amount Raised: $500,000
Mabylon AG

Schlieren, Zurich, Switzerland

Biotech from the University of Zurich developing human antibodies to treat neurological diseases and severe allergies.

BiotechnologyHealth CareTherapeutics
GrantSep 24, 2024
Amount Raised: $1,544,769
ProJenX

New Suffolk, New York, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

BiopharmaBiotechnologyHealth CareTherapeutics
GrantJun 20, 2024
Amount Raised: $1,000,000
Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
GrantFeb 16, 2024
Myrobalan Therapeutics

Medford, Massachusetts, United States

Myrobalan Therapeutics is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.

BiotechnologyHealth CareTherapeutics
GrantFeb 7, 2024
Amount Raised: $400,000
InFlectis BioScience

Nantes, Pays de la Loire, France

InFlectis BioScience is a private drug discovery company aiming at targeting.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
GrantJan 3, 2024
Amount Raised: $943,000
Oryzon Genomics SA

Barcelona, Catalonia, Spain

Oryzon Genomics is a biopharmaceutical company developing epigenetics-based therapeutics for patients with cancer and CNS disorders.

BiopharmaBiotechnologyGeneticsHealth CareMedicalTherapeutics
GrantDec 4, 2023
Amount Raised: $498,690
EverythingALS

Seattle, Washington, United States

EverythingALS is a information technology company that provides services for patients, caregivers, researchers, and drug companies.

Artificial Intelligence (AI)Cloud ComputingInformation TechnologyNon Profit
GrantAug 22, 2023
Amount Raised: $400,000
Tiziana Life Sciences

London, England, United Kingdom

Tiziana Life Sciences is a UK biotechnology company.

Biotechnology
GrantSep 15, 2022
ImmunoBrain Checkpoint

Ness Ziona, HaMerkaz, Israel

ImmunoBrain Checkpoint is a biopharmaceutical company.

BiotechnologyHealth CarePharmaceutical
GrantApr 1, 2020
Amount Raised: $500,000